United States Human Liver Models Market Growth & Industry Outlook | Major Players 2025 - Corning Incorporated, BioIVT LLC, Emulate Inc.

"Global Human Liver Models Market reached US$ 1.37 billion in 2024 and is expected to reach US$ 3.76 billion by 2033, growing at a CAGR of 12.3% during the forecast period of 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/human-liver-models-market?sp

United States: Recent Industry Developments

✅ In September 2025, Emulate Inc. launched its next-generation human liver-on-a-chip model, integrating microfluidics and AI-driven metabolic analysis. The system enables pharmaceutical companies to better predict drug toxicity and efficacy. It targets preclinical research and precision medicine applications.

✅ In August 2025, Hurel Corporation completed the acquisition of a U.S.-based liver tissue startup, expanding its portfolio of 3D human liver models and organoid technologies. The integration strengthens capabilities in drug development and toxicity testing. It supports more accurate and scalable in vitro studies.

✅ In July 2025, InSphero AG (U.S. operations) invested $40 million to enhance its liver microtissue production and R&D facility. The expansion focuses on high-throughput screening models for pharmaceutical and biotech companies. It enables faster and more predictive preclinical testing.

✅ In June 2025, CN Bio Innovations launched a cloud-connected liver microphysiological system for integrated drug testing and disease modeling. The platform combines advanced imaging, real-time data analytics, and tissue modeling. It helps researchers optimize drug candidates and reduce late-stage failures.

Japan: Recent Industry Developments

✅ In September 2025, Takara Bio Inc. launched an advanced human liver organoid platform for drug metabolism and toxicity studies. The system integrates 3D tissue modeling with AI-assisted analytics. It targets pharmaceutical companies and research institutions in Japan.

✅ In August 2025, FujiFilm Wako invested in developing next-generation liver-on-a-chip and organoid models for pharmaceutical testing. The initiative enhances precision drug screening and disease modeling. It supports faster drug development and improved predictive accuracy.

✅ In July 2025, Riken Center for Biosystems Dynamics completed a collaboration with a biotech startup to advance human liver microtissue technology. The partnership focuses on scalable production of liver models for drug discovery. It strengthens Japan's capabilities in preclinical research innovation.

✅ In June 2025, Hitachi High-Tech Corporation launched a cloud-integrated human liver model platform combining microfluidics, real-time monitoring, and AI analytics. The system enables precise evaluation of drug toxicity and metabolism. It supports pharmaceutical development and regenerative medicine research.

Human Liver Models Market: Drivers

The human liver models market is witnessing growth due to increasing demand for physiologically relevant platforms in drug discovery, toxicology testing, and disease research. Human liver models, including 3D cultures, organoids, and microphysiological systems, enable researchers to study liver function, metabolism, and drug-induced liver injury with greater accuracy than traditional animal models. Rising investments in pharmaceutical research, personalized medicine, and regenerative medicine are driving adoption of advanced liver models. Technological advancements in tissue engineering, microfluidics, and stem cell differentiation are enhancing model reliability, reproducibility, and scalability. Additionally, regulatory emphasis on reducing animal testing and improving preclinical study predictability is further supporting market growth.

Innovations in high-throughput screening, co-culture systems, and organ-on-a-chip platforms are enabling more complex, functional, and human-relevant liver models. Growing focus on hepatotoxicity assessment, drug metabolism studies, and liver disease modeling is boosting demand in both academic and industrial research. Integration with computational modeling, AI-driven analytics, and imaging technologies is enhancing data accuracy, predictive capability, and workflow efficiency. Collaborations between biotechnology firms, research institutions, and pharmaceutical companies are accelerating development and adoption of next-generation liver models. Collectively, these factors are driving steady growth in the human liver models market as the life sciences sector increasingly prioritizes accurate, ethical, and efficient platforms for liver-related research and drug development.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/human-liver-models-market?sp

Human Liver Models Market: Major Players

Corning Incorporated, BioIVT LLC, Emulate Inc., InSphero, Organovo Holdings Inc., MIMETAS B.V., CN Bio Innovations Ltd, CELLINK, Visikol, Inc., and Cyprotex PLC, among others.

Segment Covered in the Human Liver Models Market:

➥ By Product Type: 2D Models, 3D Models

➥ By Application: ADME Studies, Drug Discovery, Toxicology Testing, Disease Modelling, Others

➥ By End-user: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations

Research Process:

Both primary and secondary data sources have been used in the Human Liver Models Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Human Liver Models Market Research Industry:

➠ Who leads the Human Liver Models industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Human Liver Models market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Human Liver Models market growth?
➠ What are the dominant sales and distribution strategies in the Human Liver Models industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=human-liver-models-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.